Advocacy

The January 30, 2026 announcement of a Unified NIH Funding Strategy marks one of the most consequential shifts in federal biomedical research...

National Institutes of Health (NIH) Director Dr. Jayanta “Jay” Bhattacharya faced a pointed round of bipartisan scrutiny at a Senate...

Friends — Michigan has world-class science, a proud manufacturing legacy and thousands of bioscience jobs. But the cold truth is this:...

A sweeping government funding package now before the U.S. Senate carries major implications for the life sciences sector - touching drug...

The recent White House announcement of “The Great Healthcare Plan” landed with familiar fanfare: bold promises to lower drug prices,...

A coalition of life sciences investors, Incubate, says capital is beginning to flow back into rare disease drug development, citing more than $1...

MichBio invites Michigan’s bio-industry community to join two upcoming federal legislative fly-ins in Washington, DC, offering direct...

In a detailed response to the White House Office of Science and Technology Policy (OSTP), the Biotechnology Innovation Organization (BIO) urged...

This month, the U.S. Food and Drug Administration (FDA) took a notable step toward modernizing oversight of digital health technologies -...

The U.S. Department of Health and Human Services (HHS) has formally lent its support to the Give Kids A Chance Act - landmark legislation...

Mergers and acquisitions (M&A) are a defining feature of the global life sciences industry. While often discussed in terms of market...

The U.S. Food and Drug Administration (FDA) has taken a noteworthy step toward modernizing how it collaborates with innovative technology...